StockData
OptimizeRx Corp logo

OptimizeRx Corp (OPRX) stock

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$7.31+0.37 (+5.33%)

Close on Nov 18, 2026Market cap $137.69MP/E 30.5Yield –

OptimizeRx operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

OptimizeRx's operating income for the twelve months ending Jun 30, 2026 was $10.93M. For fiscal 2025 it was $11.69M. The highest annual figure on record is $11.69M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.69M–
FY2024Dec 31, 2024-$13.71M–
FY2023Dec 31, 2023-$26.40M–
FY2022Dec 31, 2022-$12.29M-3503.7%
FY2021Dec 31, 2021$361.10K–
FY2020Dec 31, 2020-$2.14M–
FY2019Dec 31, 2019-$3.69M-2150.5%
FY2018Dec 31, 2018$180.13K–
FY2017Dec 31, 2017-$2.13M–
FY2016Dec 31, 2016-$1.58M–
FY2015Dec 31, 2015-$597.41K–
FY2014Dec 31, 2014-$1.03M–
FY2013Dec 31, 2013-$267.54K–
FY2012Dec 31, 2012-$454.92K–
FY2011Dec 31, 2011-$1.45M–
FY2010Dec 31, 2010-$1.85M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$88.00K-102.7%
Q1 FY2026Mar 31, 2026$396.00K–
Q4 FY2025Dec 31, 2025$8.57M+135.8%
Q3 FY2025Sep 30, 2025$2.05M–
Q2 FY2025Jun 30, 2025$3.21M–
Q1 FY2025Mar 31, 2025-$2.10M–
Q4 FY2024Dec 31, 2024$3.63M–
Q3 FY2024Sep 30, 2024-$8.56M–
Q2 FY2024Jun 30, 2024-$3.75M–
Q1 FY2024Mar 31, 2024-$5.03M–
Q4 FY2023Dec 31, 2023-$10.90M–
Q3 FY2023Sep 30, 2023-$3.55M–
Q2 FY2023Jun 30, 2023-$4.85M-880.7%
Q1 FY2023Mar 31, 2023-$7.06M-18594.4%
Q4 FY2022Dec 31, 2022-$864.35K-354.1%
Q1 FY2022Mar 31, 2022-$3.76M–
Q4 FY2021Dec 31, 2021$621.08K-54.2%
Q3 FY2021Sep 30, 2021$38.19K–
Q2 FY2021Jun 30, 2021$340.14K–
Q1 FY2021Mar 31, 2021-$638.31K–
Q4 FY2020Dec 31, 2020$1.36M+182.6%
Q3 FY2020Sep 30, 2020-$176.72K-233.7%
Q2 FY2020Jun 30, 2020-$1.06M–
Q1 FY2020Mar 31, 2020-$2.26M-1112.3%
Q2 FY2019Jun 30, 2019$480.04K+75.5%
Q1 FY2019Mar 31, 2019$132.17K–
Q4 FY2018Dec 31, 2018-$125.45K–
Q3 FY2018Sep 30, 2018$223.18K–
Q2 FY2018Jun 30, 2018$273.60K–
Q1 FY2018Mar 31, 2018-$191.20K–
Q4 FY2017Dec 31, 2017-$239.31K–
Q3 FY2017Sep 30, 2017-$629.66K–
Q2 FY2017Jun 30, 2017-$370.56K–
Q1 FY2017Mar 31, 2017-$890.44K–
Q4 FY2016Dec 31, 2016-$367.93K–
Q3 FY2016Sep 30, 2016-$249.22K–
Q2 FY2016Jun 30, 2016-$602.52K–
Q1 FY2016Mar 31, 2016-$361.83K–

More OptimizeRx figures

See a number that looks wrong?